EIF4E2 and cancer: In 2014, several cancer cell lines stably depleted for eIF4E2 (U87MG glioblastoma, 786-O renal cell carcinoma, and HCT116 colorectal carcinoma) displayed impaired proliferation and increased apoptosis only in hypoxia [22].